# clm_94BE166D8C14

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 11,190,400,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-04-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1841AFF1FDCA  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 11,190,400,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_94BE166D8C14, https://asof.is/claim/clm_94BE166D8C14, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000162/0000059478-23-000162-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-04-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947823000162/0000059478-23-000162-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-04-27)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 10,649,800,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_94BE166D8C14](/claim/clm_94BE166D8C14.md) | [clm_F3CEC0454BF6](/claim/clm_F3CEC0454BF6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.